Streamline Health Solutions (NASDAQ: STRM) is one of 50 public companies in the “Healthcare Facilities & Services” industry, but how does it contrast to its rivals? We will compare Streamline Health Solutions to similar companies based on the strength of its risk, earnings, profitability, analyst recommendations, valuation, institutional ownership and dividends.
Insider and Institutional Ownership
38.5% of Streamline Health Solutions shares are owned by institutional investors. Comparatively, 69.9% of shares of all “Healthcare Facilities & Services” companies are owned by institutional investors. 26.1% of Streamline Health Solutions shares are owned by company insiders. Comparatively, 14.8% of shares of all “Healthcare Facilities & Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
This table compares Streamline Health Solutions and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Streamline Health Solutions||-24.50%||-53.33%||-15.25%|
|Streamline Health Solutions Competitors||9.73%||0.86%||0.87%|
Earnings and Valuation
This table compares Streamline Health Solutions and its rivals top-line revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Streamline Health Solutions||$26.32 million||-$3.17 million||-4.35|
|Streamline Health Solutions Competitors||$6.06 billion||$868.72 million||35.89|
Streamline Health Solutions’ rivals have higher revenue and earnings than Streamline Health Solutions. Streamline Health Solutions is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This is a breakdown of current recommendations for Streamline Health Solutions and its rivals, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Streamline Health Solutions||0||0||0||0||N/A|
|Streamline Health Solutions Competitors||264||1563||1960||38||2.46|
As a group, “Healthcare Facilities & Services” companies have a potential downside of 8.75%. Given Streamline Health Solutions’ rivals higher possible upside, analysts clearly believe Streamline Health Solutions has less favorable growth aspects than its rivals.
Volatility and Risk
Streamline Health Solutions has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500. Comparatively, Streamline Health Solutions’ rivals have a beta of 1.02, suggesting that their average share price is 2% more volatile than the S&P 500.
Streamline Health Solutions rivals beat Streamline Health Solutions on 8 of the 9 factors compared.
About Streamline Health Solutions
Streamline Health Solutions, Inc. is engaged in providing healthcare information technology through the licensing of its Electronic Health Information Management, Patient Financial, Coding and Clinical Documentation Improvement (CDI), and other Workflow software applications, and the use of such applications by software as a service. The Company also provides implementation and consulting services to complement its software solutions. The Company provides computer software-based solutions through its Looking Glass platform. The Company sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships. The Company’s software and services allow hospitals and integrated healthcare delivery systems in the United States and Canada to capture, store, manage, route, retrieve and process patient clinical, financial and other healthcare provider information.
Receive News & Ratings for Streamline Health Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.